Suppr超能文献

RNA 结合蛋白 HuR 拮抗 microRNA miR-331-3p 对前列腺癌细胞中 ERBB-2 基因表达的抑制作用。

The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells.

机构信息

Laboratory for Cancer Medicine, Western Australian Institute for Medical Research and University of Western Australia Centre for Medical Research, Royal Perth Hospital, Perth, Western Australia 6000, Australia.

Laboratory for Cancer Medicine, Western Australian Institute for Medical Research and University of Western Australia Centre for Medical Research, Royal Perth Hospital, Perth, Western Australia 6000, Australia; School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia 6008, Australia.

出版信息

J Biol Chem. 2011 Dec 2;286(48):41442-41454. doi: 10.1074/jbc.M111.301481. Epub 2011 Oct 4.

Abstract

ERBB-2 overexpression is associated with the development and progression of cancer and mediates its resistance to therapy. It has been suggested that post-transcriptional mechanisms control the overexpression of ERBB-2 in prostate cancer (PCa). We recently demonstrated that the 3'-untranslated region (3'-UTR) of ERBB-2 mRNA contains two specific target sites for binding of the microRNA miR-331-3p and that miR-331-3p represses ERBB-2 expression and signaling in PCa cells. Here we investigate a U-rich element situated in close proximity to the distal miR-331-3p target site in the ERBB-2 3'-UTR. Specific binding of HuR to this U-rich element promotes ERBB-2 expression in PCa cells. We show that HuR antagonizes the repressive action of miR-331-3p on its distal ERBB-2 3'-UTR target site. These results support a model in which the interplay between RNA-binding proteins and microRNAs controls the post-transcriptional regulation of gene expression and suggest that both HuR and miR-331-3p participate in the overexpression of ERBB-2 observed in some PCas.

摘要

erbB-2 过表达与癌症的发生和发展有关,并介导其对治疗的耐药性。已经有人提出,转录后机制控制着前列腺癌(PCa)中 erbB-2 的过表达。我们最近证明,erbB-2 mRNA 的 3'-非翻译区(3'-UTR)包含两个特定的结合位点,供 microRNA miR-331-3p 结合,并且 miR-331-3p 在 PCa 细胞中抑制 erbB-2 的表达和信号传导。在这里,我们研究了位于 erbB-2 3'-UTR 中远端 miR-331-3p 靶位点附近的富含 U 的元件。HuR 特异性结合该 U 富含元件可促进 PCa 细胞中 erbB-2 的表达。我们表明 HuR 拮抗 miR-331-3p 对其远端 erbB-2 3'-UTR 靶位点的抑制作用。这些结果支持了一种模型,即 RNA 结合蛋白和 microRNAs 之间的相互作用控制基因表达的转录后调控,并表明 HuR 和 miR-331-3p 都参与了一些 PCa 中观察到的 erbB-2 的过表达。

相似文献

1
The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells.
J Biol Chem. 2011 Dec 2;286(48):41442-41454. doi: 10.1074/jbc.M111.301481. Epub 2011 Oct 4.
2
The interplay of HuR and miR-3134 in regulation of AU rich transcriptome.
RNA Biol. 2013 Aug;10(8):1283-90. doi: 10.4161/rna.25482. Epub 2013 Jun 20.
4
miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer.
J Biol Chem. 2009 Sep 11;284(37):24696-704. doi: 10.1074/jbc.M109.030098. Epub 2009 Jul 7.
8
The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2.
Mol Cancer Res. 2012 Jan;10(1):167-80. doi: 10.1158/1541-7786.MCR-11-0337. Epub 2011 Nov 2.

引用本文的文献

2
Deciphering 3'UTR Mediated Gene Regulation Using Interpretable Deep Representation Learning.
Adv Sci (Weinh). 2024 Oct;11(39):e2407013. doi: 10.1002/advs.202407013. Epub 2024 Aug 19.
5
6
The androgen receptor messenger RNA: what do we know?
RNA Biol. 2022 Jan;19(1):819-828. doi: 10.1080/15476286.2022.2084839.
7
HuR-dependent SOD2 protein synthesis is an early adaptation to anchorage-independence.
Redox Biol. 2022 Jul;53:102329. doi: 10.1016/j.redox.2022.102329. Epub 2022 May 13.
8
AGO-RBP crosstalk on target mRNAs: Implications in miRNA-guided gene silencing and cancer.
Transl Oncol. 2022 Jul;21:101434. doi: 10.1016/j.tranon.2022.101434. Epub 2022 Apr 26.
9
Circular RNAs and Drug Resistance in Genitourinary Cancers: A Literature Review.
Cancers (Basel). 2022 Feb 9;14(4):866. doi: 10.3390/cancers14040866.
10
Long Non-Coding RNA H19 Regulates Glioma Cell Growth and Metastasis miR-200a-Mediated CDK6 and ZEB1 Expression.
Front Oncol. 2021 Nov 2;11:757650. doi: 10.3389/fonc.2021.757650. eCollection 2021.

本文引用的文献

1
The changing therapeutic landscape of castration-resistant prostate cancer.
Nat Rev Clin Oncol. 2011 Aug 9;8(10):597-610. doi: 10.1038/nrclinonc.2011.117.
2
Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy.
Am J Pathol. 2011 Jul;179(1):46-54. doi: 10.1016/j.ajpath.2011.03.008. Epub 2011 May 3.
5
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
Nat Med. 2011 Feb;17(2):211-5. doi: 10.1038/nm.2284. Epub 2011 Jan 16.
7
MicroRNA regulation of growth factor receptor signaling in human cancer cells.
Methods Mol Biol. 2011;676:147-63. doi: 10.1007/978-1-60761-863-8_11.
8
Her-2/neu expression in prostate adenocarcinoma: a systematic review and meta-analysis.
J Urol. 2010 Sep;184(3):842-50. doi: 10.1016/j.juro.2010.04.077.
10
Signatures of RNA binding proteins globally coupled to effective microRNA target sites.
Genome Res. 2010 Aug;20(8):1010-9. doi: 10.1101/gr.103259.109. Epub 2010 May 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验